<DOC>
	<DOCNO>NCT02034344</DOCNO>
	<brief_summary>The purpose study obtain skin , blood , urine sample patient active cutaneous lupus lesion healthy participant .</brief_summary>
	<brief_title>A Study Skin Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers</brief_title>
	<detailed_description>This Phase 0 multi-center longitudinal study biomarkers clinical parameter patient lupus erythematosus ( LE ) . Approximately 80 participant ( 20 healthy participant 60 patient LE ) enrol . This include 30 Discoid Lupus Erythematosus/Subacute Cutaneous Lupus Erythematosus ( DLE/SCLE ) without Systemic Lupus Erythematosus ( SLE ) , 30 DLE/SCLE SLE . All patient LE continue manage personal physician per standard-of-care . Study participant undergo interventional procedure include collection urine , blood sample skin biopsy . There single sample collection timepoint healthy participant two sample collection timepoints LE patient , separate approximately 12 week . A blood sample genomic analysis collect research purpose patient provide consent local regulation permit . The data obtain study use evaluation new therapy lupus may help develop new treatment . Safety evaluation include assessment adverse event , clinical laboratory test , vital sign , physical examination . The total duration study participation approximately 11 day healthy participant 95 day patient LE .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Lupus Erythematosus , Cutaneous</mesh_term>
	<mesh_term>Lupus Erythematosus , Discoid</mesh_term>
	<criteria>Have Discoid Lupus Erythematosus ( DLE ) Subacute Cutaneous Lupus Erythematosus ( SCLE ) without diagnosis Systemic Lupus Erythematosus ( SLE ) Active DLE active SCLE confirm histological analysis ( participant DLE SCLE without SLE ) Confirmed diagnosis SLE use American College Rheumatology criterion current historical positive antinuclear antibody ( ANA ) anti doublestranded deoxyribonucleic acid ( antidsDNA ) ( participant DLE SCLE SLE ) An active skin lesion biopsied ( participant lupus erythematosus ) Known think diagnosis druginduced lupus An active skin disease manifestation lupus erythematosus Has acute cutaneous lupus erythematosus rash If take antimalarial therapy stable dose least 8 week Day 1 Participants treat great 10mg/day prednisone therapy equivalent last 4 week prior Day 1 Positive serology human immunodeficiency virus antibody , hepatitis B virus , hepatitis C virus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Lupus Erythematosus , Cutaneous</keyword>
	<keyword>Lupus Erythematosus , Systemic</keyword>
	<keyword>Lupus Erythematosus , Discoid</keyword>
	<keyword>Healthy</keyword>
	<keyword>Active Cutaneous Lupus Erythematosus</keyword>
	<keyword>Longitudinal Study</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Subacute Cutaneous Lupus Erythematosus</keyword>
	<keyword>Skin Biopsy</keyword>
</DOC>